These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
394 related items for PubMed ID: 16873644
21. HIV/AIDS: Latin America & Caribbean. The Caribbean. Cohen J. Science; 2006 Jul 28; 313(5786):470. PubMed ID: 16873640 [No Abstract] [Full Text] [Related]
22. Methadone maintenance treatment of heroin abuse in China. Lu L, Zhao D, Bao YP, Shi J. Am J Drug Alcohol Abuse; 2008 Jul 28; 34(2):127-31. PubMed ID: 18293229 [No Abstract] [Full Text] [Related]
23. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after. Cohen J. Science; 2006 Jul 28; 313(5786):484-7. PubMed ID: 16873654 [No Abstract] [Full Text] [Related]
24. Intravenous heroin use: its association with HIV infection in patients in methadone treatment. Chu A, Brown LS, Banks S, Nemoto T, Primm BJ. NIDA Res Monogr; 1989 Jul 28; 95():447-8. PubMed ID: 2641025 [No Abstract] [Full Text] [Related]
25. HIV/AIDS: Latin America & Caribbean. Mexico & Central America. Cohen J. Science; 2006 Jul 28; 313(5786):477. PubMed ID: 16873646 [No Abstract] [Full Text] [Related]
27. HIV infection and AIDS in Latin America. Epidemiologic features and clinical manifestations. Murillo J, Castro KG. Infect Dis Clin North Am; 1994 Mar 28; 8(1):1-11. PubMed ID: 8021440 [Abstract] [Full Text] [Related]
28. Tracing the regional rise of HIV. Cohen J. Science; 2010 Jul 09; 329(5988):161. PubMed ID: 20616263 [No Abstract] [Full Text] [Related]
29. Mosaic of the AIDS epidemics in Latin America and the Caribbean. Cuchi P, Patz D. J Int Assoc Physicians AIDS Care; 1998 Jul 09; 4(7):36-7. PubMed ID: 11365641 [Abstract] [Full Text] [Related]
30. Thirty years into the AIDS pandemic. Aronson SM. Med Health R I; 2011 Oct 09; 94(10):283. PubMed ID: 22164656 [No Abstract] [Full Text] [Related]
31. Can HIV epidemics among injection drug users be prevented? Strathdee SA, van Ameijden EJ, Mesquita F, Wodak A, Rana S, Vlahov D. AIDS; 1998 Oct 09; 12 Suppl A():S71-9. PubMed ID: 9632987 [No Abstract] [Full Text] [Related]
32. HIV/AIDS in India. The needle and the damage done. Cohen J. Science; 2004 Apr 23; 304(5670):509-12. PubMed ID: 15105472 [No Abstract] [Full Text] [Related]
35. HIV/AIDS: Latin America & Caribbean. Peru: a new nexus for HIV/AIDS research. Cohen J. Science; 2006 Jul 28; 313(5786):488-90. PubMed ID: 16873657 [No Abstract] [Full Text] [Related]
37. The invisible IDU. Raymond D. GMHC Treat Issues; 2005 Jul 28; 19(5-6):16. PubMed ID: 16193580 [No Abstract] [Full Text] [Related]
38. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Abdul-Quader A, Heckathorn DD, McKnight C, Bramson H, Nemeth C, Torian LV, Friedman SR. AIDS; 2007 Jan 11; 21(2):231-5. PubMed ID: 17197815 [Abstract] [Full Text] [Related]
39. The art and the science of scaling-up needle and syringe programmes. Bedell R. Addiction; 2007 Aug 11; 102(8):1179-80. PubMed ID: 17624968 [No Abstract] [Full Text] [Related]
40. Drug use, harm reduction, and health policies in Argentina: obstacles and new perspectives. Inchaurraga S. Clin Infect Dis; 2003 Dec 15; 37 Suppl 5():S366-71. PubMed ID: 14648449 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]